Home > Photo >

FIVB suspends two players for anti-doping rule violation

2009-07-25 22:29 Xinhuanet

BELGRADE, July 24 (Xinhua) -- The International Federation de Volleyball (FIVB) announced on Thursday the decision in Lausanne over the suspension of Daniela Lanner Mapeli of Brazil and Riley Salmon from the United States.

The FIVB anti-doping Hearing Panel heard the players on Wednesday before coming to the following conclusion that Mapeli has committed an anti-doping rule violation according to the FIVB Medical Regulations and the panel imposes on her a sanction of three-month suspension.

Mapeli's violation resulted from her taking the over-the-counter flu medication Gripefago C, which contains the prohibited substance isometheptene, during the CEV Women's Final Four in Rome on March 14, 2009. The suspension started on July 22, 2009.

American player Riley Salmon has committed an anti-doping rule violation according to the FIVB Medical Regulations and the panel imposes on him a sanction of four-month suspension.

The violation came from a miscommunication between the player and his physician regarding medication he was taking as treatment for hypertension during an out-of-competition test taken on April 5, 2009.

Salmon was then training in Villorba of Italy with his Sisley Treviso club. While his regular medication Avapro is allowed, the replacement drug Avalide contains the prohibited substance hydrochlorothizide.

Slamon's period of suspension began on May 27, 2009, the date the athlete was provisionally suspended pending the hearing.

"Although any violation of the anti-doping regulations must be taken seriously, none of these cases resulted from intentional doping," said FIVB Medical Commission President Roald Bahr.

Related Story